Synonym
ABX-196; ABX 196; ABX196
IUPAC/Chemical Name
N-((2S,3S,4R)-1-(((2S,3R,4S,5R,6R)-6-(acetamidomethyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxyoctadecan-2-yl)tetracosanamide
InChi Key
VITDDUXZOHEQMU-BYSUZVQFSA-N
InChi Code
InChI=1S/C50H98N2O9/c1-4-6-8-10-12-14-16-18-19-20-21-22-23-24-25-26-28-30-32-34-36-38-45(55)52-42(40-60-50-49(59)48(58)47(57)44(61-50)39-51-41(3)53)46(56)43(54)37-35-33-31-29-27-17-15-13-11-9-7-5-2/h42-44,46-50,54,56-59H,4-40H2,1-3H3,(H,51,53)(H,52,55)/t42-,43+,44+,46-,47-,48-,49+,50-/m0/s1
SMILES Code
CCCCCCCCCCCCCCCCCCCCCCCC(N[C@H]([C@@H]([C@@H](CCCCCCCCCCCCCC)O)O)CO[C@H]1O[C@@H]([C@@H]([C@@H]([C@H]1O)O)O)CNC(C)=O)=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
871.34
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Tefit JN, Crabé S, Orlandini B, Nell H, Bendelac A, Deng S, Savage PB, Teyton
L, Serra V. Efficacy of ABX196, a new NKT agonist, in prophylactic human
vaccination. Vaccine. 2014 Oct 21;32(46):6138-45. doi:
10.1016/j.vaccine.2014.08.070. Epub 2014 Sep 13. PMID: 25218293; PMCID:
PMC4233108.
2: Scherrer D, Barrett N, Teyton L, Pearce T, Nitcheu J, Pouletty P, Santo J,
Ehrlich HJ. Demonstration of the Antitumor Activity of the iNKT Agonist ABX196,
a Novel Enhancer of Cancer Immunotherapy, in Melanoma and Hepatocarcinoma Mouse
Models. Mol Cancer Ther. 2022 Dec 2;21(12):1788-1797. doi:
10.1158/1535-7163.MCT-22-0183. PMID: 36198025; PMCID: PMC9716246.